Exchange: NASDAQ·Updated 07:50 PM EDT
GILD logo

GILD Gilead Sciences, Inc.

$151.17
$4.07
(2.77%)
Today
Closed $151.17
$0.03
(0.02%)
After Hours
EarningsOct 29
Mkt Cap$187.44B
Vol5.8M

About GILD

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
43

Bearish Sentiment

How do you feel about GILD?

gpaisa
$GILD decade long base breakout and retest here in 2026. Seems so straight foward and simple this year doesn't it lol.
2
BigAllergies
$GILD comes up Strong at a 16 on the quality momentum scanner right now, 8th of 259 in Biotech
2
Pope_of_Profit
$GILD preparing for the breakout. it had a ton of crazy runs in the past, why not another one
1
dustlesspuma
🟢 $GILD 147C Sep 25 💰 $52,300 premium 💵 $3.35/contract 📊 3.3x Vol/OI 📍 Spot $148.64 🚨 Repeat sweep 🌊 Dark Flow | Options Flow
1
BioTechStockZ
$GILD so when will this old compamy finally make a 30 USD/share offering for Kyverna to stay to date with modern medicine?
BioTechStockZ
$GILD a strategic acquisition like Kyverna t cell immnutherapy would make me more bullish about this dying star

Advertisement|Remove ads.